Defunct Company
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
115
NCT00354926
Safety and Efficacy Study of an Anti-CD20 Monoclonal Antibody (AME-133v) to Treat Non-Hodgkin's Lymphoma
Phase: Phase 1
Role: Lead Sponsor
Start: Jul 31, 2006
Completion: Jan 31, 2009
NCT00689507
A Phase 1 Safety Study of LY2127399 in Combination With Bortezomib
Start: Mar 31, 2008
Completion: May 31, 2014